Cargando…

A Simple and Rapid Method Based on Liquid Chromatography-Tandem Mass Spectrometry for the Measurement of α-L-Iduronidase Activity in Dried Blood Spots: An Application to Mucopolysaccharidosis I (Hurler) Screening

BACKGROUND: We developed an analytical method to measure α-L-iduronidase (IDUA) activity in dried blood spots. This was achieved by using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) with electrospray ionization in the positive ion mode. METHODS: Chromatographic separation wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jeong Soo, Min, Hye Kyeong, Oh, Hyeon Ju, Woo, Hye In, Lee, Soo-Youn, Kim, Jong-Won, Song, Junghan, Park, Hyung-Doo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272964/ https://www.ncbi.nlm.nih.gov/pubmed/25553279 http://dx.doi.org/10.3343/alm.2015.35.1.41

Ejemplares similares

Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates
por: Choi, Rihwa, et al.
Publicado: (2019)

α-L-iduronidase therapy for mucopolysaccharidosis type I
por: Tolar, Jakub, et al.
Publicado: (2008)

Dried Blood Spot Testing for Seven Steroids Using Liquid Chromatography-Tandem Mass Spectrometry With Reference Interval Determination in the Korean Population
por: Kim, Borahm, et al.
Publicado: (2015)

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
por: Moore, David, et al.
Publicado: (2008)

Open issues in Mucopolysaccharidosis type I-Hurler
por: Parini, Rossella, et al.
Publicado: (2017)

Insights into Mucopolysaccharidosis I from the structure and action of α-L-Iduronidase
por: Bie, Haiying, et al.
Publicado: (2013)

Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Quantification of Plasma Metanephrines for Differential Diagnosis of Adrenal Incidentaloma
por: Lee, Sae-Mi, et al.
Publicado: (2015)

Multiplex Assay of Second-Line Anti-Tuberculosis Drugs in Dried Blood Spots Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
por: Lee, Kyunghoon, et al.
Publicado: (2016)

Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry
por: Kim, Hyung Min, et al.
Publicado: (2019)

Hurler Syndrome (Mucopolysaccharidosis Type 1): A Case Report
por: Khalid, Noman, et al.
Publicado: (2023)

Dried Blood Spot Technique-Based Liquid Chromatography-Tandem Mass Spectrometry Method as a Simple Alternative for Benznidazole Pharmacokinetic Assessment
por: Galindo Bedor, Danilo César, et al.
Publicado: (2018)

Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
por: Li, Ying, et al.
Publicado: (2022)

Use of Liquid Chromatography-Tandem Mass Spectrometry for Clinical Testing in Korean Laboratories: a Questionnaire Survey
por: Chae, Hyojin, et al.
Publicado: (2019)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
por: Langan, Thomas J., et al.
Publicado: (2020)

Quantification of Warfarin in Dried Rat Plasma Spots by High-Performance Liquid Chromatography with Tandem Mass Spectrometry
por: Chernonosov, Alexander
Publicado: (2016)

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide
por: Filali-Ansary, Aziz, et al.
Publicado: (2016)

Mucopolysaccharidosis type I Hurler-Scheie syndrome affecting two sisters
por: Anand, Reena, et al.
Publicado: (2015)

High-Throughput Liquid Chromatography–Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II
por: Wang, Junhua, et al.
Publicado: (2020)

Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report
por: Tatapudi, Ramesh, et al.
Publicado: (2011)

Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
por: Chkioua, Latifa, et al.
Publicado: (2011)

Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients
por: Chkioua, Latifa, et al.
Publicado: (2011)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
por: Sun, Luning, et al.
Publicado: (2011)

Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry
por: Moon, Soo Young, et al.
Publicado: (2014)

Hurler's Disease with Multiple Atypical Mongolian Spots
por: Sonthalia, Sidharth, et al.
Publicado: (2016)

Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
por: Harahap, Yahdiana, et al.
Publicado: (2020)

Development and Validation of Doxorubicin Hydrochloride and Doxorubicinol Quantification Method in Dried Blood Spot by Liquid Chromatography–Tandem Mass Spectrometry
por: Harahap, Yahdiana, et al.
Publicado: (2020)

Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I
por: Kwak, Min Jung, et al.
Publicado: (2016)

Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice
por: Kida, Sachiho, et al.
Publicado: (2023)

Analysis of Acrylamide and Glycidamide in Dried Blood Spot of Smokers Using Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry
por: Harahap, Yahdiana, et al.
Publicado: (2022)

Stability of glyoxal- and methylglyoxal-modified hemoglobin on dried blood spot cards as analyzed by nanoflow liquid chromatography tandem mass spectrometry
por: Chen, Hauh-Jyun Candy, et al.
Publicado: (2018)

The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2016)

Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation
por: Schmidt, Mona, et al.
Publicado: (2016)

Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Measurement of Leukocyte Arylsulfatase A Activity Using a Natural Substrate
por: Han, Minje, et al.
Publicado: (2015)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
por: Pineda, Tatiana, et al.
Publicado: (2014)

Analysis of Acid Sphingomyelinase Activity in Dried Blood Spots Using Tandem Mass Spectrometry
por: Legnini, Elisa, et al.
Publicado: (2012)

A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I
por: Prommajan, Korrakot, et al.
Publicado: (2011)

Simple and fast quantification of cannabinoids in animal feeds by liquid chromatography–tandem mass spectrometry
por: Xu, Xin, et al.
Publicado: (2023)

Method Development and Validation for Measuring O(6)-Methylguanine in Dried Blood Spot Using Ultra High-Performance Liquid Chromatography Tandem Mass Spectrometry
por: Harahap, Yahdiana, et al.
Publicado: (2021)

Improvement in functional gait parameters following corrective thoracolumbar surgery in children affected by Mucopolysaccharidosis 1 (Hurler syndrome)
por: Sundarapandian, Rajkumar, et al.
Publicado: (2020)

Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler
por: Jin, Xiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7mjshs5o77b74iaonu9p5q6o2k